Articoli correlati a Expression of FMD Virus Like Particles (VLPs) Using...
Sinossi
Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Risultati della ricerca per Expression of FMD Virus Like Particles (VLPs) Using...
Foto dell'editore
Expression of FMD Virus Like Particles (VLPs) Using Baculovirus System
Editore:
LAP LAMBERT Academic Publishing Dez 2022, 2022
ISBN 10: 6205528010
ISBN 13: 9786205528013
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating. 100 pp. Englisch. Codice articolo 9786205528013
Compra nuovo
EUR 60,90
Spedizione EUR 23,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 2 disponibili
Immagini fornite dal venditore
Expression of FMD Virus Like Particles (VLPs) Using Baculovirus System
Editore:
LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6205528010
ISBN 13: 9786205528013
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating. Codice articolo 9786205528013
Compra nuovo
EUR 87,23
Spedizione EUR 30,50
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
Expression of FMD Virus Like Particles (VLPs) Using Baculovirus System
Editore:
LAP LAMBERT Academic Publishing Dez 2022, 2022
ISBN 10: 6205528010
ISBN 13: 9786205528013
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Currently Inactivated serotype specific FMD vaccine is used worldwide for the control of FMD virus. This requires cost intensive high-containment facility, which however poses the risk of virus escape from such facility. Over last few years, research has been ongoing to produce non-infectious, safer vaccine for FMD. To address these concerns, research is ongoing worldwide to develop recombinant vaccines for FMD that are safe to produce, yet effective at eliciting protective immunity in animals. In this context, expression from the Baculovirus system offers the potential for large-scale production of non-infectious FMDV capsids. Virus-like Particles (VLPs), a result of recombinant DNA technology, are formed by viral structural proteins that can inherently self-assemble and mimic the morphology of the virus, without being infective or replicating.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 100 pp. Englisch. Codice articolo 9786205528013
Compra nuovo
EUR 60,90
Spedizione EUR 60,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili